Jiangsu Hengrui Medicine repurchases shares for employee stock plan

Jiangsu Hengrui Medicine announced a repurchase of 70,000 A-shares on October 29, 2025, which will be held as treasury shares. The repurchase was conducted on the Shanghai Stock Exchange, with prices ranging from RMB 62.9 to RMB 63.58 per share, totaling an expenditure of RMB 4,427,711. This move is intended for the company's A-share employee stock ownership plan.

As of October 28, 2025, the company's issued shares (excluding treasury shares) stood at 6,363,005,164, with 15,997,110 treasury shares. Following the repurchase, the number of issued shares decreased by 70,000 to 6,362,935,164. The treasury shares increased to 16,067,110.

The total number of ordinary shares remains at 6,379,002,274. This transaction reflects the company's strategy to utilize share repurchases in support of its employee incentive programs, aligning with its internal governance and regulatory compliance as per the SSE listing rules.